Cannabis-Based Medicines in Gastroparesis and Related Syndromes – AtlantiCare
Cannabis medicines gastroparesis offer promising antiemetic benefits for patients with delayed gastric emptying. Targeting the endocannabinoid system may improve symptoms like nausea and vomiting. Careful selection of cannabinoid formulations is…
Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research
Cannabinoid hyperemesis is a paradoxical condition causing severe vomiting in some heavy cannabis users. This syndrome often leads to costly misdiagnosis and emergency visits. Understanding cannabinoid hyperemesis helps clinicians identify and manage…
Delta-9-Tetrahydrocannabinol alleviates chemotherapy-induced weight loss but not colitis
Delta-9-tetrahydrocannabinol weight loss effects were studied in a preclinical model showing benefits against chemotherapy-induced weight loss. This research highlights THC's potential in managing weight loss during chemotherapy. However,…
Australian Trial to Test Medicinal Cannabis Against Chemotherapy’s Gut Side Effects
Cannabinoid clinical trials for chemotherapy mucositis are underway to evaluate CBD/THC's potential in preventing gastrointestinal side effects. This phase II trial tests sublingual wafers in adults receiving mucotoxic chemotherapy. Results are pending,…
The dual roles of natural cannabidiol in combating oxidative stress and inflammation: A potential intestinal guardian.
CBD antioxidant anti-inflammatory effects play a crucial role in protecting the intestinal tract by reducing oxidative stress and inflammation. This natural compound modulates key pathways to preserve gut barrier integrity. Understanding these effects…